Sonic Healthcare Gross Profit 2023-2025 | SKHHY

Sonic Healthcare annual/quarterly gross profit history and growth rate from 2023 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Sonic Healthcare gross profit for the quarter ending December 31, 2025 was $0M, a 0% increase year-over-year.
  • Sonic Healthcare gross profit for the twelve months ending December 31, 2025 was $0M, a 0% increase year-over-year.
  • Sonic Healthcare annual gross profit for 2025 was $2.194B, a 5.45% increase from 2024.
  • Sonic Healthcare annual gross profit for 2024 was $2.081B, a 2.32% increase from 2023.
  • Sonic Healthcare annual gross profit for 2023 was $2.034B, a 27.93% decline from 2022.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Sonic Healthcare Annual Gross Profit
(Millions of US $)
2025 $2,194
2024 $2,081
2023 $2,034
2022 $2,822
2021 $2,822
Sonic Healthcare Quarterly Gross Profit
(Millions of US $)
Sector Industry Market Cap Revenue
Medical Medical Services $6.732B $6.246B
Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services and their collective patients. Sonic Healthcare Limited is based in Sydney, Australia.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $148.899B 26.08
CVS Health (CVS) United States $113.624B 11.33
HCA Healthcare (HCA) United States $92.600B 14.40
Elevance Health (ELV) United States $89.122B 13.98
Cencora (COR) United States $58.924B 18.00
Natera (NTRA) United States $53.245B 0.00
Labcorp Holdings (LH) United States $26.010B 18.34
Viatris (VTRS) United States $19.469B 6.73
Medpace Holdings (MEDP) United States $17.091B 35.89
EUROFINS SCIENT (ERFSF) Luxembourg $16.888B 0.00
DiDi Global (DIDIY) China $16.776B 184.00
Revvity (RVTY) United States $16.007B 26.81
Solventum (SOLV) United States $15.123B 12.51
Charles River Laboratories (CRL) United States $13.274B 28.09
ICON (ICLR) Ireland $12.565B 17.08
BrightSpring Health Services (BTSG) United States $11.235B 38.63
Avantor (AVTR) United States $10.497B 18.93
BioMerieux (BMXMF) France $9.856B 0.00
Caris Life Sciences,�Inc (CAI) United States $8.472B 83.28
HealthEquity (HQY) United States $7.870B 25.64
PACS (PACS) United States $6.666B 22.40
GETINGE (GNGBY) Sweden $6.516B 18.40
CochLear (CHEOY) Australia $6.200B 0.00
MiniMed (MMED) United States $6.131B 0.00
Bausch + Lomb (BLCO) Canada $6.021B 22.77
Sotera Health (SHC) United States $5.345B 22.04
Concentras Parent (CON) United States $4.523B 22.31
Organon (OGN) United States $3.592B 4.56
GeneDx Holdings (WGS) United States $3.015B 280.83
CareDx (CDNA) United States $2.785B 316.65
Amplifon S.p.A (AMFPF) Italy $2.465B 12.74
Pediatrix Medical (MD) United States $2.107B 12.35
COMPASS Pathways (CMPS) United Kingdom $2.103B 0.00
Progyny (PGNY) United States $2.082B 29.49
Establishment Labs Holdings (ESTA) United States $2.065B 0.00
Bora Pharmaceuticals, - (BORAY) Taiwan $2.011B 12.08
Sonida Senior Living (SNDA) United States $1.839B 0.00
Freenome (FRNM) United States $1.838B 0.00
Surgery Partners (SGRY) United States $1.735B 66.25
Alignment Healthcare (ALHC) United States $1.732B 43.95
Agilon Health (AGL) United States $1.497B 0.00
InnovAge Holding (INNV) United States $1.490B 0.00
Ardent Health (ARDT) United States $1.478B 8.45
Nutex Health (NUTX) United States $1.430B 8.20
Omada Health (OMDA) United States $1.251B 255.38
Ryman Healthcare (RYHTY) New Zealand $1.241B 0.00
GoodRx Holdings (GDRX) United States $1.158B 22.53
Teladoc Health (TDOC) United States $1.145B 0.00
CryoPort (CYRX) United States $0.862B 0.00
Enhabit (EHAB) United States $0.709B 25.89
GMR Solutions (GMRS) United States $0.677B 0.00
Forward Industries (FWDI) United States $0.569B 0.00
Oncology Institute (TOI) United States $0.507B 0.00
Charming Medical (MCTA) Hong Kong, SAR China $0.504B 0.00
SBC Medicals (SBC) United States $0.489B 10.11
Strata Critical Medical (SRTA) United States $0.472B 0.00
Shoulder Innovations (SI) United States $0.378B 0.00
Auna S.A (AUNA) Luxembourg $0.377B 5.48
Biodesix (BDSX) United States $0.308B 0.00
Embecta (EMBC) United States $0.300B 2.59
So-Young (SY) China $0.279B 0.00
LifeMD (LFMD) United States $0.155B 0.00
Ascend Wellness Holdings (AAWH) United States $0.101B 0.00
Park Dental Partners (PARK) United States $0.097B 0.00
SkinHealth Systems (SKIN) United States $0.088B 0.00
Sera Prognostics (SERA) United States $0.082B 0.00
QDM (QDMI) Hong Kong, SAR China $0.073B 8.67
Tevogen (TVGN) United States $0.051B 0.00
DocGo (DCGO) United States $0.036B 0.00
Lifeward (LFWD) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.016B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.013B 0.00
Ainos (AIMD) United States $0.011B 0.00
XWELL (XWEL) United States $0.008B 0.00
Aclarion (ACON) United States $0.007B 0.00
Basel Medical Group (BMGL) Singapore $0.007B 0.00
IceCure Medical (ICCM) Israel $0.007B 0.00
Co-Diagnostics (CODX) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
Pomdoctor - (POM) China $0.006B 0.00
Pheton Holdings (PTHL) China $0.006B 0.00
20/20 Biolabs (AIDX) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Synergy CHC (SNYR) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00